The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Decreasing BMI/weight immediately prior to starting anti-PD-1/PDL-1 monoclonal antibodies for treatment for stage IV non-small cell lung cancer is associated with shorter progression-free survival.
 
Revathi Kollipara
No Relationships to Disclose
 
Ibtihaj Fughhi
No Relationships to Disclose
 
Marta Batus
No Relationships to Disclose
 
Sanjib Basu
No Relationships to Disclose
 
Jeffrey Allen Borgia
Research Funding - Abbott; Biodesix; Epigenomics
 
Philip D. Bonomi
Honoraria - AstraZeneca; Biodesix; Bristol-Myers Squibb; Helsinn Therapeutics; Lilly; Merck; pfizer; Roche/Genentech; Trovagene
Consulting or Advisory Role - AstraZeneca; Biodesix; Bristol-Myers Squibb; Helsinn Therapeutics; Lilly; Merck; Merck; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Mary J. Fidler
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Genentech; Genentech (I); Guardant Health; Guardant Health
Speakers' Bureau - Genentech; Merck
Research Funding - Biodesix